$SRNE
Sorrento Therapeutics Inc Stock $srne

$srne Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000085026118000013 Filed on March 16, 2018

Income Statement

Concept	2016 Q4	2016 Q3	2016 Q2
Revenue	$4.019M	$2.243M	$902.0K
YoY Change	200.6%	103.35%	-23.1%
Cost Of Revenue	-$300.0K	$418.0K	$295.0K
YoY Change	-160.0%	-30.79%	-6.05%
Gross Profit	$4.300M	$1.825M	$607.0K
YoY Change	437.5%	265.73%	-29.34%
Gross Profit Margin	106.99%	81.36%	67.29%
Selling, General & Admin	$10.20M	$5.300M	$4.200M
YoY Change	0.99%	12.77%	35.48%
% of Gross Profit	237.21%	290.41%	691.93%
Research & Development	$13.60M	$10.38M	$32.00M
YoY Change	63.86%	-56.86%	301.46%
% of Gross Profit	316.28%	568.88%	5271.83%
Depreciation & Amortization	$1.670M	$500.0K	$400.0K
YoY Change	215.09%	21.95%	-34.43%
% of Gross Profit	38.84%	27.4%	65.9%
Operating Expenses	$16.20M	$10.38M	$32.00M
YoY Change	-12.9%	-56.86%	301.46%
Operating Profit	-$11.90M	-$12.25M	-$44.71M
YoY Change	-33.15%	-65.63%	324.49%
Interest Expense	-$600.0K	$236.0K	$273.0K
YoY Change	-92.31%	-40.4%	-38.24%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$12.70M	$15.55M	-$44.47M
YoY Change	-50.0%	-53.23%	305.19%
Income Tax	$0.00	-$195.0K	$0.00
% Of Pretax Income		-1.25%
Net Earnings	-$17.86M	$15.89M	-$43.31M
YoY Change	-32.86%	-1792.33%	295.19%
Net Earnings / Revenue	-444.36%	708.47%	-4801.0%
Basic Earnings Per Share		$0.24	-$0.93
Diluted Earnings Per Share	-$204.4K	$0.24	-$0.93
COMMON SHARES
Basic Shares Outstanding	58.63M shares	66.19M shares	46.50M shares
Diluted Shares Outstanding	58.63M shares	66.53M shares	46.50M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.50M	$67.70M	$133.1M
YoY Change	-38.78%	-45.18%	157.45%
Cash & Equivalents	$82.40M	$66.20M	$98.18M
Short-Term Investments	$1.100M	$1.200M	$34.90M
Other Short-Term Assets	$3.200M	$1.100M	$600.0K
YoY Change	60.0%	57.14%	-50.0%
Inventory
Prepaid Expenses
Receivables	$1.700M	$500.0K	$900.0K
Other Receivables	$1.300M	$2.600M	$11.70M
Total Short-Term Assets	$89.65M	$71.80M	$146.3M
YoY Change	-36.42%	-42.47%	171.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.71M	$10.10M	$9.203M
YoY Change	75.37%	164.88%	228.68%
Goodwill	$41.50M		$20.63M
YoY Change	101.2%
Intangibles
YoY Change
Long-Term Investments	$76.99M	$171.4M	$59.09M
YoY Change	32.48%	185.67%	174.84%
Other Assets	$3.909M	$1.500M	$524.0K
YoY Change	562.54%	200.0%	-12.96%
Total Long-Term Assets	$311.9M	$207.3M	$205.1M
YoY Change	54.04%	3.39%	159.62%
TOTAL ASSETS
Total Short-Term Assets	$89.65M	$71.80M	$146.3M
Total Long-Term Assets	$311.9M	$207.3M	$205.1M
Total Assets	$401.6M	$279.1M	$351.4M
YoY Change	16.9%	-14.2%	164.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.282M	$1.400M	$4.423M
YoY Change	518.52%	-12.5%	78.78%
Accrued Expenses	$4.741M	$7.300M	$37.10M
YoY Change	22.29%	48.98%	3981.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$209.0K	$5.188M	$5.067M
YoY Change	-95.68%	9.87%	9.84%
Total Short-Term Liabilities	$76.09M	$36.04M	$61.03M
YoY Change	146.45%	38.27%	489.01%
LONG-TERM LIABILITIES
Long-Term Debt	$47.11M	$458.0K	$1.801M
YoY Change	972.08%	-91.89%	-73.78%
Other Long-Term Liabilities	$138.7M	$135.0M	$118.3M
YoY Change	17.54%	20.21%	421.15%
Total Long-Term Liabilities	$47.11M	$458.0K	$1.801M
YoY Change	972.08%	-91.89%	-73.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.09M	$36.04M	$61.03M
Total Long-Term Liabilities	$47.11M	$458.0K	$1.801M
Total Liabilities	$315.1M	$206.6M	$216.2M
YoY Change	55.53%	551.35%	420.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$174.3M		-$176.7M
YoY Change	53.76%		98.7%
Common Stock	$303.9M	$336.6M	$337.0M
YoY Change	64.34%		87.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$49.46M	$51.49M
YoY Change
Treasury Stock Shares	7.568M shares
Shareholders Equity	$80.04M	$79.70M	$142.2M
YoY Change
Total Liabilities & Shareholders Equity	$401.6M	$279.1M	$351.4M
YoY Change	16.9%	-14.2%	164.58%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016 Q2
OPERATING ACTIVITIES
Net Income	-$17.86M	$15.89M	-$43.31M
YoY Change	-32.86%	-1792.33%	295.19%
Depreciation, Depletion And Amortization	$1.670M	$500.0K	$400.0K
YoY Change	215.09%	21.95%	-34.43%
Cash From Operating Activities	-$16.52M	-$22.05M	-$12.17M
YoY Change	2.23%	20.1%	-1036.15%
INVESTING ACTIVITIES
Capital Expenditures	-$3.170M	-$1.460M	-$1.630M
YoY Change	80.11%	0.69%	918.75%
Acquisitions
YoY Change
Other Investing Activities	-$9.240M	-$1.350M	$0.00
YoY Change		-104.86%	-100.0%
Cash From Investing Activities	-$12.41M	-$2.810M	-$1.630M
YoY Change	605.11%	-110.68%	-83.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	45.13M	-7.120M	91.17M
YoY Change	-2238.86%	1106.78%	151850.0%
NET CHANGE
Cash From Operating Activities	-16.52M	-22.05M	-12.17M
Cash From Investing Activities	-12.41M	-2.810M	-1.630M
Cash From Financing Activities	45.13M	-7.120M	91.17M
Net Change In Cash	16.20M	-31.98M	77.37M
YoY Change	-180.88%	-534.51%	-979.2%
FREE CASH FLOW
Cash From Operating Activities	-$16.52M	-$22.05M	-$12.17M
Capital Expenditures	-$3.170M	-$1.460M	-$1.630M
Free Cash Flow	-$13.35M	-$20.59M	-$10.54M
YoY Change	-7.29%	21.76%	-821.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000850261
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87434049	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	153000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Sorrento Therapeutics, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Trading Symbol TradingSymbol	SRNE
CY2013Q3	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	8.00
CY2014Q4	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	12.99
CY2016Q4	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	4.89
CY2017	srne	Accretion Of Debt Issuance Costs And Other AccretionOfDebtIssuanceCostsAndOther	0	USD
CY2017	srne	Adjustments To Additional Paid In Capital Acquisition Adjustments AdjustmentsToAdditionalPaidInCapitalAcquisitionAdjustments	-2027000	USD
CY2013Q3	srne	Class Of Warrant Exercisable Term ClassOfWarrantExercisableTerm	P7Y
CY2014Q4	srne	Class Of Warrant Exercisable Term ClassOfWarrantExercisableTerm	P7Y
CY2015	srne	Common Stock Received In Exchange For License CommonStockReceivedInExchangeForLicense	100000000	USD
CY2016	srne	Common Stock Received In Exchange For License CommonStockReceivedInExchangeForLicense	0	USD
CY2017	srne	Common Stock Received In Exchange For License CommonStockReceivedInExchangeForLicense	0	USD
CY2015	srne	Contributions To Equity Method Investment ContributionsToEquityMethodInvestment	60000000	USD
CY2016	srne	Contributions To Equity Method Investment ContributionsToEquityMethodInvestment	0	USD
CY2017	srne	Contributions To Equity Method Investment ContributionsToEquityMethodInvestment	0	USD
CY2017Q4	srne	Debt Instrument Unamortized Interest On Debt DebtInstrumentUnamortizedInterestOnDebt	12500000	USD
CY2015	srne	Deferred Rent And Other Period Increase Decrease DeferredRentAndOtherPeriodIncreaseDecrease	0	USD
CY2016	srne	Deferred Rent And Other Period Increase Decrease DeferredRentAndOtherPeriodIncreaseDecrease	-2535000	USD
CY2017	srne	Deferred Rent And Other Period Increase Decrease DeferredRentAndOtherPeriodIncreaseDecrease	639000	USD
CY2016Q4	srne	Deferred Tax Assets Amortization Of Intangible DeferredTaxAssetsAmortizationOfIntangible	32032000	USD
CY2017Q4	srne	Deferred Tax Assets Amortization Of Intangible DeferredTaxAssetsAmortizationOfIntangible	21862000	USD
CY2016Q4	srne	Deferred Tax Assets Operating Loss And Credit Carryforwards DeferredTaxAssetsOperatingLossAndCreditCarryforwards	6237000	USD
CY2017Q4	srne	Deferred Tax Assets Operating Loss And Credit Carryforwards DeferredTaxAssetsOperatingLossAndCreditCarryforwards	21172000	USD
CY2016Q4	srne	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	1530000	USD
CY2017Q4	srne	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	757000	USD
CY2016	srne	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	0	USD
CY2017	srne	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount	10006000	USD
CY2016	srne	Effective Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost True Up Amount EffectiveIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCostTrueUpAmount	0	USD
CY2017	srne	Effective Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost True Up Amount EffectiveIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCostTrueUpAmount	1788000	USD
CY2015	srne	Gain Loss On Contingent Liabilities GainLossOnContingentLiabilities	0	USD
CY2016	srne	Gain Loss On Contingent Liabilities GainLossOnContingentLiabilities	-8121000	USD
CY2017	srne	Gain Loss On Contingent Liabilities GainLossOnContingentLiabilities	0	USD
CY2015	srne	Gain Losson Extinguishment Of Debt Adjustment GainLossonExtinguishmentOfDebtAdjustment	0	USD
CY2016	srne	Gain Losson Extinguishment Of Debt Adjustment GainLossonExtinguishmentOfDebtAdjustment	0	USD
CY2017	srne	Gain Losson Extinguishment Of Debt Adjustment GainLossonExtinguishmentOfDebtAdjustment	-4275000	USD
CY2016	srne	Income Tax Reconciliation Nondeductible Expense Tax Credits Research And Development IncomeTaxReconciliationNondeductibleExpenseTaxCreditsResearchAndDevelopment	2360000	USD
CY2017	srne	Income Tax Reconciliation Nondeductible Expense Tax Credits Research And Development IncomeTaxReconciliationNondeductibleExpenseTaxCreditsResearchAndDevelopment	-71000	USD
CY2016	srne	Income Tax Reconciliation Other Permanent Differences IncomeTaxReconciliationOtherPermanentDifferences	2882000	USD
CY2017	srne	Income Tax Reconciliation Other Permanent Differences IncomeTaxReconciliationOtherPermanentDifferences	1290000	USD
CY2016	srne	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	-16000	USD
CY2017	srne	Income Tax Reconciliation Return To Provision Adjustment IncomeTaxReconciliationReturnToProvisionAdjustment	-42000	USD
CY2016	srne	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-1836000	USD
CY2017	srne	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	1027000	USD
CY2017Q4	srne	Long Term Debt Maturities Repayments Of Principal Amount LongTermDebtMaturitiesRepaymentsOfPrincipalAmount	62500000	USD
CY2014Q4	srne	Maximum Amount Registered For Future Issuance Of Securities MaximumAmountRegisteredForFutureIssuanceOfSecurities	50000000	USD
CY2016Q4	srne	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Exercisable NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercisable	306748	shares
CY2014Q1	srne	Number Of Banks NumberOfBanks	2	bank
CY2013Q3	srne	Number Of Banks NumberOfBanks	2	bank
CY2015Q2	srne	Number Of Joint Ventures To Be Funded NumberOfJointVenturesToBeFunded	2	joint_venture
CY2017	srne	Number Of Screened And Validated Targets NumberOfScreenedAndValidatedTargets	100	target
CY2015	srne	Payments For Repurchase Of Common Stock For Deferred Compensation Obligations PaymentsForRepurchaseOfCommonStockForDeferredCompensationObligations	2000000	USD
CY2016	srne	Payments For Repurchase Of Common Stock For Deferred Compensation Obligations PaymentsForRepurchaseOfCommonStockForDeferredCompensationObligations	0	USD
CY2017	srne	Payments For Repurchase Of Common Stock For Deferred Compensation Obligations PaymentsForRepurchaseOfCommonStockForDeferredCompensationObligations	1012000	USD
CY2015	srne	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	-3095000	USD
CY2016	srne	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	48320000	USD
CY2017	srne	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	0	USD
CY2014Q4	srne	Shelf Registration Statement Amount Maximum ShelfRegistrationStatementAmountMaximum	250000000	USD
CY2015	srne	Stock Issued During Period Value Upon Achievement Of Milestone StockIssuedDuringPeriodValueUponAchievementOfMilestone	0	USD
CY2015	srne	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	USD
CY2017	srne	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit	10000000	USD
CY2015	srne	Tax Effected Interest On Convertible Securities TaxEffectedInterestOnConvertibleSecurities	0	USD
CY2016	srne	Tax Effected Interest On Convertible Securities TaxEffectedInterestOnConvertibleSecurities	0	USD
CY2017	srne	Tax Effected Interest On Convertible Securities TaxEffectedInterestOnConvertibleSecurities	71000	USD
CY2016Q4	srne	Trading Securities Accumulated Gross Realized Gain Loss Before Tax TradingSecuritiesAccumulatedGrossRealizedGainLossBeforeTax	356000	USD
CY2017Q4	srne	Trading Securities Accumulated Gross Realized Gain Loss Before Tax TradingSecuritiesAccumulatedGrossRealizedGainLossBeforeTax	-309000	USD
CY2015	srne	Trading Securities Realized Gain Loss Adjustments TradingSecuritiesRealizedGainLossAdjustments	0	USD
CY2016	srne	Trading Securities Realized Gain Loss Adjustments TradingSecuritiesRealizedGainLossAdjustments	0	USD
CY2017	srne	Trading Securities Realized Gain Loss Adjustments TradingSecuritiesRealizedGainLossAdjustments	-665000	USD
CY2016	srne	Warrants Issued WarrantsIssued	1377000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8282000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9911000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4741000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7274000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4922000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9378000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-118000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	242000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	303865000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	413901000	USD
CY2015	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1157000	USD
CY2016	us-gaap	Adjustment For Amortization AdjustmentForAmortization	845000	USD
CY2017	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2610000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	32062000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	12669000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	477000	USD
CY2016Q4	us-gaap	Assets Assets	401586000	USD
CY2017Q4	us-gaap	Assets Assets	431613000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	89654000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	29700000	USD
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	83504000	USD
CY2017Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20870000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1106000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	441000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	27193000	USD
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	48362000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	53209000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2396000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71902000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39038000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82398000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20429000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-32864000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	43360000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-62034000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	32990232	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50882856	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82903567	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50882856	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82903567	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27768000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-134620000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9492000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4263000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3014000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1977000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	23505000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-137634000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	11469000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	112000000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	112008000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	237008000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	237000000	USD
CY2015	us-gaap	Cost Method Investments Realized Gain Loss CostMethodInvestmentsRealizedGainLoss	0	USD
CY2016	us-gaap	Cost Method Investments Realized Gain Loss CostMethodInvestmentsRealizedGainLoss	0	USD
CY2017	us-gaap	Cost Method Investments Realized Gain Loss CostMethodInvestmentsRealizedGainLoss	116249000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	1950000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	811000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	3945000	USD
CY2015	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2016	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2017	us-gaap	Costmethod Investments Other Than Temporary Impairment CostmethodInvestmentsOtherThanTemporaryImpairment	0	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	78595000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	23002000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	23000000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	45613000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	45600000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	68600000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	14500000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	14491000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	83100000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	21823000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	104929000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	28200000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	18123000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	24993000	USD
CY2017Q4	us-gaap	Costs And Expenses CostsAndExpenses	55205000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	126521000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2500000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1785000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-366000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	30000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3121000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-2385000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-322000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	621000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-600000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	14000	USD
CY2017	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	32100000	USD
CY2017	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	32062000	USD
CY2017Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000000	USD
CY2014Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0795
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12700000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12669000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	44705000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	44800000	USD
CY2016Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1012000	USD
CY2017Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	32378000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3554000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-33178000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	84000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	33193000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1489000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35716000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	66371000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	63698000	USD
CY2015	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	33337000	USD
CY2016	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	982000	USD
CY2017	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-35679000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	248000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	212000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9666000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3864000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	134376000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	119287000	USD
CY2015	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	9876000	USD
CY2016	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	23534000	USD
CY2017	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	-20891000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	815000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2065000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2538000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	44754000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	34754000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	94172000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	91568000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13133000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	48163000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5693000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	10160000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3898000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1743000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	1558000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	1877000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81039000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43405000	USD
CY2016	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5520000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43400000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	53238000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	15535000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	25433000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	15225000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	39408000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	47716000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	53238000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15535000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	237000	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	424000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	658000	USD
CY2015	us-gaap	Depreciation Depreciation	1134000	USD
CY2016	us-gaap	Depreciation Depreciation	1951000	USD
CY2017	us-gaap	Depreciation Depreciation	4470000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2370000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2885000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7079000	USD
CY2015	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3360000	USD
CY2017	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	5500000	USD
CY2015Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5500000	USD
CY2017Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2015	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	3400000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.93
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.40
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.24
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.91
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.21
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2015	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	0	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	0	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash EffectOfExchangeRateOnCash	65000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3565000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4485000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	76994000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	32999000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	983000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	1380000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	48362000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	54272000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1753000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4362000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	49698000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3697000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5002000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5002000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3807000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3807000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66519000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75375000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	64766000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71013000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-178000	USD
CY2015	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	69274000	USD
CY2016	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2015	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	0	USD
CY2016	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	-163000	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-59000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-222000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4300000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4275000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20132000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24219000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38332000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	41548000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	41500000	USD
CY2017	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-4645000	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36314000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-896000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-36038000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	22783000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-38431000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-172000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	810000	USD
CY2016	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	0	USD
CY2017	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	408000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	38298000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	38300000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1395000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9719000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-65268000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15315000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4041000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	435000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40244000	USD
CY2017	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	0	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23357000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8725000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	767000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1025000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	120000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	715000	USD
CY2016	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	4133000	USD
CY2017	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-1095000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1522000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-834000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2318000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	4051000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3001000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	34000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1289000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1715000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2713000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3714000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1592000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	10582000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1673000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2323000	USD
CY2015	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1715000	USD
CY2016	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	448000	USD
CY2017	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-233000	USD
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	920000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1052000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1902000	USD
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	176000	USD
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	472000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	515000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	27000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	604000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000	shares
CY2015	us-gaap	Interest Expense InterestExpense	1652000	USD
CY2016	us-gaap	Interest Expense InterestExpense	1610000	USD
CY2017	us-gaap	Interest Expense InterestExpense	4980000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1574000	USD
CY2016	us-gaap	Interest Paid InterestPaid	1342000	USD
CY2017	us-gaap	Interest Paid InterestPaid	3499000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	24000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	272000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	241000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1630000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2054000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3237000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	315084000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	225003000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	401586000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	431613000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76085000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78955000	USD
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	48362000	USD
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	54272000	USD
CY2015	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2016	us-gaap	Licenses Revenue LicensesRevenue	4017000	USD
CY2017	us-gaap	Licenses Revenue LicensesRevenue	140381000	USD
CY2014Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	12500000.0	USD
CY2013Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	5000000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	5211000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	209000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	50134000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2366000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2500000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2500000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2500000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2500000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47107000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5211000	USD
CY2017	us-gaap	Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount	0	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	6465000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	7042000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3347000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	131740000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53675000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12552000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17452000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16529000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42069000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-70928000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-99180000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-45811000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-15650000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-43300000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-43305000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-59000000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	15900000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	15891000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-43100000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-17859000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-60923000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-23064000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-14187000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-2061000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	48444000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	9132000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4263000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3014000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1977000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45811000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60923000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9061000	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1	31250	shares
CY2014Q4	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1	34642	shares
CY2016Q4	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1	460123	shares
CY2015	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	49000	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-74005000	USD
CY2017	us-gaap	Paid In Kind Interest PaidInKindInterest	1326000	USD
CY2015	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-27759000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-96777000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	25335000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	41258000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	5304000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5004000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4949000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5315000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5287000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	15399000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3909000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3250000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	360000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	73579000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-73697000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	360000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	73579000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-73579000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	14294000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-14294000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q4	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	4278000	USD
CY2017Q4	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	6015000	USD
CY2015	us-gaap	Paid In Kind Interest PaidInKindInterest	392000	USD
CY2016	us-gaap	Paid In Kind Interest PaidInKindInterest	164000	USD
CY2016	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	USD
CY2017	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15639000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016Q4	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	49000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3842000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	557000	USD
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11500000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3707000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6860000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10972000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3165000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4904000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	107986000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	57928000	USD
CY2013Q3	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	5000000	USD
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	49000	USD
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2015	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	USD
CY2016	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	USD
CY2017	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	49916000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1699000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	524000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-50074000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-63937000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	11109000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17630000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28723000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12707000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19345000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1696000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2211000	USD
CY2013Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	762000	USD
CY2015	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2016	us-gaap	Repayments Of Debt RepaymentsOfDebt	9451000	USD
CY2017	us-gaap	Repayments Of Debt RepaymentsOfDebt	53157000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24013000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45000000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26102000	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	31343000	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	42175000	USD
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	55532000	USD
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	12000000	USD
CY2016	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46498000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66193000	shares
CY2016Q1	us-gaap	Revenues Revenues	988000	USD
CY2016Q2	us-gaap	Revenues Revenues	902000	USD
CY2016Q3	us-gaap	Revenues Revenues	2243000	USD
CY2016Q4	us-gaap	Revenues Revenues	4019000	USD
CY2017	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-174252000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165120000	USD
CY2015	us-gaap	Revenue From Grants RevenueFromGrants	1530000	USD
CY2016	us-gaap	Revenue From Grants RevenueFromGrants	1033000	USD
CY2017	us-gaap	Revenue From Grants RevenueFromGrants	206000	USD
CY2015	us-gaap	Revenues Revenues	4590000	USD
CY2016	us-gaap	Revenues Revenues	8152000	USD
CY2017Q1	us-gaap	Revenues Revenues	4874000	USD
CY2017Q2	us-gaap	Revenues Revenues	4665000	USD
CY2017Q3	us-gaap	Revenues Revenues	121910000	USD
CY2017Q4	us-gaap	Revenues Revenues	20407000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	199568000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108713000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	140938000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	86502000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	206610000	USD
CY2017	us-gaap	Revenues Revenues	151856000	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3060000	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3102000	USD
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	11269000	USD
CY2017Q4	us-gaap	Security Deposit SecurityDeposit	1482000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	6972000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	4741000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1699000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	527000	USD
CY2016	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	108301000	USD
CY2016Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	7878098	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	80037000	USD
CY2016Q4	us-gaap	Trading Securities TradingSecurities	1106000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	441000	USD
CY2016Q4	us-gaap	Trading Securities Cost TradingSecuritiesCost	750000	USD
CY2017Q4	us-gaap	Trading Securities Cost TradingSecuritiesCost	750000	USD
CY2015	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	0	USD
CY2016	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	356000	USD
CY2017	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	-665000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7568182	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	7568182	shares
CY2016	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19061000	USD
CY2017	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3055000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	57928000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	50807000	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49464000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49464000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2389000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3883000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Foreign Currency Translation UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1436000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	58000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	4952000	USD
CY2017	us-gaap	Standardized Measure Of Discounted Future Net Cash Flow Relating To Proved Oil And Gas Reserves Accretion Of Discount StandardizedMeasureOfDiscountedFutureNetCashFlowRelatingToProvedOilAndGasReservesAccretionOfDiscount	26000	USD
CY2015	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	6972000	USD
CY2016	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	4741000	USD
CY2017	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	4952000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	90000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-38400000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	25350000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	39605000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81039000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	43405000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	14255000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	41434000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	0	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0	USD
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	38431000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	0	USD
CY2016	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	0	USD
CY2017	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	797000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36909000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37965000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46498000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58634000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50360000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66527000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58634000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50360000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50886000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50886000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70302000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76888000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82996000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70381000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36909000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37965000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70302000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	76887000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80486000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69742000	shares
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000850261-18-000013-index-headers.html	Edgar Link	pending
0000850261-18-000013-index.html	Edgar Link	pending
0000850261-18-000013.txt	Edgar Link	pending
0000850261-18-000013-xbrl.zip	Edgar Link	pending
a2017performancegraph.jpg	Edgar Link	pending
ex231.htm	Edgar Link	pending
exhibit121.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit232.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
painfranchise.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sorrentoimage2a01.jpg	Edgar Link	pending
srne-20171231.xml	Edgar Link	completed
srne-20171231.xsd	Edgar Link	pending
srne-20171231_cal.xml	Edgar Link	unprocessable
srne-20171231_def.xml	Edgar Link	unprocessable
srne-20171231_lab.xml	Edgar Link	unprocessable
srne-20171231_pre.xml	Edgar Link	unprocessable
srne12312017-10k.htm	Edgar Link	pending
srnepartnersa01.jpg	Edgar Link	pending
technologygrapha01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SRNE
Sorrento Therapeutics Inc Stock $srne

2016 Q4 Form 10-K Financial Statement

#000085026118000013 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRNE Sorrento Therapeutics Inc Stock $srne

2016 Q4 Form 10-K Financial Statement

#000085026118000013 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRNE
Sorrento Therapeutics Inc Stock $srne